Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Angiogenesis inhibitors generated by tumors.

Literature DB >> 8529090

Angiogenesis inhibitors generated by tumors.

J Folkman¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1995 PMID： 8529090 PMCID： PMC2229937

Source DB: PubMed Journal: Mol Med ISSN： 1076-1551 Impact factor: 6.354

× No keyword cloud information.

14 in total

1. Identification of an inhibitor of neovascularization from cartilage.

Authors: M A Moses; J Sudhalter; R Langer
Journal: Science Date: 1990-06-15 Impact factor: 47.728

2. Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor.

Authors: T Oikawa; M Hasegawa; M Shimamura; H Ashino; S Murota; I Morita
Journal: Biochem Biophys Res Commun Date: 1991-12-31 Impact factor: 3.575

3. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha.

Authors: S J Leibovich; P J Polverini; H M Shepard; D M Wiseman; V Shively; N Nuseir
Journal: Nature Date: 1987 Oct 15-21 Impact factor: 49.962

4. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

Authors: F Rastinejad; P J Polverini; N P Bouck
Journal: Cell Date: 1989-02-10 Impact factor: 41.582

5. Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors: J Folkman; K Watson; D Ingber; D Hanahan
Journal: Nature Date: 1989-05-04 Impact factor: 49.962

Review 6. Tumor angiogenesis: therapeutic implications.

Authors: J Folkman
Journal: N Engl J Med Date: 1971-11-18 Impact factor: 91.245

7. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

Authors: D J Good; P J Polverini; F Rastinejad; M M Le Beau; R S Lemons; W A Frazier; N P Bouck
Journal: Proc Natl Acad Sci U S A Date: 1990-09 Impact factor: 11.205

8. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma.

Authors: J Kandel; E Bossy-Wetzel; F Radvanyi; M Klagsbrun; J Folkman; D Hanahan
Journal: Cell Date: 1991-09-20 Impact factor: 41.582

Review 9. Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis.

Authors: I Vlodavsky; G Korner; R Ishai-Michaeli; P Bashkin; R Bar-Shavit; Z Fuks
Journal: Cancer Metastasis Rev Date: 1990-11 Impact factor: 9.264

10. The resistance of certain tissues to invasion: penetrability of explanted tissues by vascularized mesenchyme.

Authors: R Eisenstein; N Sorgente; L W Soble; A Miller; K E Kuettner
Journal: Am J Pathol Date: 1973-12 Impact factor: 4.307

38 in total

1. Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis.

Authors: M Watanabe; K L McCormick; K Volker; J R Ortaldo; J M Wigginton; M J Brunda; R H Wiltrout; W E Fogler
Journal: Am J Pathol Date: 1997-05 Impact factor: 4.307

9. Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.

Authors: Katsuhiro Miyajima; Susumu Takekoshi; Johbu Itoh; Kochi Kakimoto; Takashi Miyakoshi; Robert Yoshiyuki Osamura
Journal: Acta Histochem Cytochem Date: 2010-04-07 Impact factor: 1.938

10. Signaling mechanisms of endogenous angiogenesis inhibitors derived from type IV collagen.

Authors: Akulapalli Sudhakar; Chandra S Boosani
Journal: Gene Regul Syst Bio Date: 2007-10-14

Angiogenesis inhibitors generated by tumors.

1. Identification of an inhibitor of neovascularization from cartilage.

2. Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor.

3. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha.

4. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

5. Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Review 6. Tumor angiogenesis: therapeutic implications.

7. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

8. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma.

Review 9. Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis.

10. The resistance of certain tissues to invasion: penetrability of explanted tissues by vascularized mesenchyme.

1. Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis.

Review 2. Therapeutic inhibition of angiogenesis.

3. Subcutaneous metastasis at a surgical drain site after the resection of pancreatic cancer.

4. Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors.

5. Low-intensity alternating electric fields: a potentially safe and effective treatment of cancer?

6. The anti-tumor properties of two tumstatin peptide fragments in human gastric carcinoma.

Review 7. Establishing a link between oncogenes and tumor angiogenesis.

8. Prognostic relevance of collagen XVIII expression in metastatic gastric carcinoma.

9. Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.

10. Signaling mechanisms of endogenous angiogenesis inhibitors derived from type IV collagen.